ERADICATE Hep C

Eradicate Hepatitis C Virus: A pilot of treatment as prevention in active drug users.

SuperDOT-C

Pharmacy-led HCV therapy versus conventional treatment pathways for HCV positive patients receiving daily OST.

ECLS Study

The largest randomised trial conducted using biomarkers for the early detection of lung cancer, in over 12,000 Scottish high-risk smokers.

BiCARB

Assessing the efficacy of sodium bicarbonate in 300 older people with chronic kidney disease.

MTAK

Microwave Therapy for the treatment of pre-cancerous Actinic Keratosis.

K-SWAY

Investigating Vitamin K supplementation to improve balance in older people – and reduce the risk of falls.

K4Kidneys

Investigating if Vitamin K therapy can improve vascular health in patients with Chronic Kidney Disease.

PACT

Online trial examining if prescribing asthma controller medication according to genotype improves quality of life in young people with asthma.

ALFIE

Investigating whether allopurinol can improve muscle strength and endurance in older people.

ALTERED

Does allopurinol regress left ventricular hypertrophy in end stage renal disease?

iLFT

A pilot evaluation of a synergistic liver diagnostic pathway: Making sense of LFTs for patients, GPs and the NHS in Scotland. Intelligent Liver Function Testing.

Award winning trial:

  • Innovation Award at the Scottish Health Awards 2019
  • Innovation in Practice Gold Award at the STAR Awards 2019
  • NHS Tayside Innovation Award at the Excellence in Patient Care Awards 2019
  • Royal College of Physicians Finalist in BMJ Digital Innovation Award

ADDUCE

Large European Union trial studying the long-term safety in ADHD treatment.

STAKT

Investigate the short term effects of an AKT inhibitor on breast cancer.

OPTIMISTIC

Evaluate the effect of a tailored behavioural change intervention comprising CBT and graded exercise on participation (as measured by the DM1-Activ scale) for severely fatigued patients with myotonic dystrophy type 1 compared to standard care.

PREFACE

Evaluate the effect of a tailored behavioural change intervention comprising CBT and graded exercise on participation (as measured by the DM1-Activ scale) for severely fatigued patients with myotonic dystrophy type 1 compared to standard care.

AMBER

Investigating whether abdominal massage can help improve the symptoms of neurogenic bowel dysfunction in people with multiple sclerosis.

adAPT

Investigating whether metformin, that is known to reduce insulin demand in type 2 diabetes (T2D), can do the same in children at risk of type 1 diabetes.

ALLAY

British Heart Foundation trial investigating whether allopurinol can regress left ventricular hypertrophy in patients with treated essential hypertension.

ViaDUCT

Investigating if Vitamin D supplementation can improve Hepatitis C cure rates.

REFORM

Research into the effects of SGLT2 inhibition on left ventricular remodelling in patients with heart failure and diabetes mellitus.

ALPHA

British Heart Foundation trial investigating if allopurinol can reduce right ventricular mass in lung disease associated pulmonary hypertension.

HAP

What is the most effective method for providing orthodontic anchorage? A randomised clinical trial of Headgear, AbsoAnchor mini-screws, and palatal arch.

ACES

Can an arts based creative engagement intervention following stroke improve psychosocial outcomes?

FFIT

A gender-sensitive weight loss and healthy living programme delivered to men aged 35-65 by Scottish Premier League (SPL) football clubs.

PIRFICT

A podiatry intervention to reduce falls in care home residents.

SPIR-OA

The effect of spironolactone on pain in older people with osteoarthritis.

VESUVIUS

Vascular effects of regular cigarettes versus electronic cigarette use.

GOAL

Can eliciting and addressing health-related goals improve asthma control and asthma-related quality of life?

Game of Stones

A research study that texts men to help them lose weight.

SKIP-IT

Text intervention as an aid to smoking cessation in pregnant women.

ALL ACS

Allopurinol as a possible new therapy for acute coronary syndrome.

DAPA-LVH

Does dapaglifozin regress left ventricular hypertrophy in patients with type 2 diabetes?